Evidence map›Paper›PMID 30669433›Full record

ArticleMolecules (Basel, Switzerland)2019

Inhibition of T Cell Receptor Activation by Semi-Synthetic Sesquiterpene Lactone Derivatives and Molecular Modeling of Their Interaction with Glutathione and Tyrosine Kinase ZAP-70.

Andrei I Khlebnikov, Igor A Schepetkin, Anarkul S Kishkentaeva, Zhanar R Shaimerdenova, Gayane A Atazhanova, Sergazy M Adekenov, Liliya N Kirpotina, Mark T Quinn

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Activity of Estafietin and Analogues onMolecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Andrei I KhlebnikovKizhner Research Center, Tomsk Polytechnic University, Tomsk 634050, Russia. aikhl@chem.org.ru.ORCID 0000-0002-3022-4510
Igor A SchepetkinDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. schepetkin@yahoo.com.
Anarkul S KishkentaevaInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan. anar_kish@mail.ru.ORCID 0000-0002-9169-3492
Zhanar R ShaimerdenovaInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan. arsenzhan@bk.ru.ORCID 0000-0003-4910-3695
Gayane A AtazhanovaInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan. g-atazhanova@mail.ru.ORCID 0000-0003-1615-9967
Sergazy M AdekenovInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan. arglabin@phyto.kz.
Liliya N KirpotinaDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. liliya@montana.edu.
Mark T QuinnDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. mquinn@montana.edu.ORCID 0000-0001-8114-5073
Montana State University · USAltai State University · RU

Funding

Ministry of Education and Science of the Russian Federation 4.8192.2017/8.9National Institutes of Health GM110732Tomsk Polytechnic University CEP - N. Kizhner Center - 213/201U.S. Department of Agriculture Hatch project 1009546
6 · The paper itself

Abstract

A variety of natural compounds have been shown to modulate T cell receptor (TCR) activation, including natural sesquiterpene lactones (SLs). In the present studies, we evaluated the biological activity of 11 novel semi-synthetic SLs to determine their ability to modulate TCR activation. Of these compounds, α -epoxyarglabin, cytisinyl epoxyarglabin, 1 β ,10 α -epoxyargolide, and chloroacetate grosheimin inhibited anti-CD3-induced Ca

Indexed as

Cell CommunicationGlutathioneHumansJurkat CellsLactonesMitogen-Activated Protein KinasesMolecular Docking SimulationMolecular StructurePhosphorylationProtein BindingProtein Kinase InhibitorsReceptors, Antigen, T-CellSesquiterpenesSignal TransductionStructure-Activity RelationshipZAP-70 Protein-Tyrosine KinaseGlutathioneLactonesMitogen-Activated Protein KinasesProtein Kinase InhibitorsReceptors, Antigen, T-CellSesquiterpenesZAP-70 Protein-Tyrosine Kinasecalcium fluxextracellular signal-regulated kinaseglutathionemolecular modelingsesquiterpene lactonesT cell receptorZAP-70

Identifiers

PMID30669433
PMCPMC6358946
OpenAlexW2908869299

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.